Tuğba Başoğlu

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

Özkan Alan, Tuğba Akın Telli, Bilge Aktaş et al. · World Journal of Surgical Oncology · 2020 · 32 citations · Full text

Medicine, Endocrinology, Oncology +14

The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy

Akif Doğan, Goncagül Akdağ, Zeynep Yüksel Yaşar et al. · Scientific Reports · 2024 · 18 citations · Full text

Medicine, Biostatistics, Oncology +17

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül et al. · International Journal of Clinical Oncology · 2021 · 16 citations

Medicine, Oncology, Pharmacotherapy +14

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

Nazım Can Demircan, Özkan Alan, Tuğba Başoğlu et al. · Journal of Oncology Pharmacy Practice · 2019 · 15 citations

Pharmacy, Oncology, Pharmacotherapy +17

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül et al. · European Urology Focus · 2020 · 13 citations

Medicine, Oncology, Pharmacotherapy +11